DA
Therapeutic Areas
Eikon Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Small Molecule Program | Oncology (Target Undisclosed) | Preclinical |
Leadership Team at Eikon Therapeutics
DR
Dr. Roger Perlmutter
Chief Executive Officer
DJ
Dr. John Leonard
Chief Scientific Officer
DL
Dr. Luke Lairson
Vice President, Discovery Chemistry
DE
Dr. Eric Betzig
Founder and Advisor
DR
Dr. Robert Tjian
Chairman of the Board
DL
David Lee
Board Member